Dose-Dependent Increases in Circulating TGF-  and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent

Title
Dose-Dependent Increases in Circulating TGF-  and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 15, Issue 7, Pages 2397-2405
Publisher
American Association for Cancer Research (AACR)
Online
2009-03-11
DOI
10.1158/1078-0432.ccr-08-1627

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search